艾伯维公司 ABBV 深 沪
等待开盘 11-13 09:30:00 美东时间
294.45
-0.530
-0.18%
华盛通- 最 高300.42
- 今 开299.30
- 成交量 482.68万股
- 最 低 294.07
- 昨 收 294.98
- 总市值 5204.75亿
- 52周最高 302.93
- 市盈率 静 124.71
- 换手率 0.27%
- 52周最低 187.29
- 委 比 -89.57%
- 总股本 17.68亿
- 历史最高 302.93
- 量 比 0.94
- 振 幅 2.15%
- 历史最低 -23.80
- 每 手 1
- 风险率 26.24%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Royalty Pharma to present at the UBS Global Biopharma Conference
Royalty Pharma plc will participate in a fireside chat at the UBS Global Biopharma Conference on November 17, 2026, at 5:40 a.m. ET / 10:40 a.m. GMT. The webcast will be available on Royalty Pharma’s website and archived for 30 days. Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties, collaborating with innovators across the industry. Its portfolio includes royalties on over 35 commercial products and 16 developme...
11-12 21:15
ADARx Reports Third Quarter 2026 Financial Results and Provides Business Updates
ADARx Pharmaceuticals reported strong financial results and key business highlights for Q3 2026, including completing an IPO and private placement generating $602.5 million in gross proceeds. The company advanced three Phase 2 trials for agazisiran, received Fast Track designation for onvuzosiran for HAE, and expanded its leadership team. With a cash position of $901 million, ADARx expects to fund operations into 2030.
11-12 21:05
艾伯维收涨0.37%，成交额9.23亿美元
11月12日，艾伯维（ABBV）收涨0.37%，报294.98美元，成交额9.23亿美元，市值5213.43亿美元。 行情数据 • 开盘价：291.36美元 ...
11-12 05:30
UDI前十大重仓股占比31.7318%，第一大重仓股为美敦力
数据显示，UDI前十大重仓股合计占基金资产的31.7318%。 其中，第一大重仓股为美敦力，持仓占比3.8314%；第二大重仓股为强生，占比3.6903%；第三...
11-07 07:18
Here's How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today
AbbVie (NYSE:ABBV) has outperformed the market over the past 10 years by 3.3% on an annualized basis producing an average annual return of 16.33%. Currently, AbbVie has a market capitalization of $509.83 billion. Buying $1000 In ABBV: If an investor had bought $1000 of ABBV stock 10 years ago, it wo...
11-07 04:15
艾伯维(ABBV.US)扩大英国牛津研发设施 押注免疫学、神经科学与肿瘤学药物创新
美国制药公司艾伯维(ABBV.US)周三表示，作为一项超过1.2亿英镑(约合1.61亿美元)投资计划的一部分，该公司已扩大其位于英国牛津的研究与开发设施。此次投...
11-04 10:35
艾伯维收跌0.98%，成交额15.32亿美元
11月4日，艾伯维（ABBV）收跌0.98%，报286美元，成交额15.32亿美元，市值5054.72亿美元。 行情数据 • 开盘价：288.69美元 • 最高...
11-04 05:30
